StockData
Danaher Corp logo

Danaher Corp

DHRNYSEIndustrial Instruments For Measurement, Display, and ControlFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 26, 2026Last filing: 10-Q on Jul 21, 2026Score 12/3027% above fair value
$232.23−4.75 (-2.00%)

Close on Oct 30, 2026Market cap $163.25BP/E 41.2Yield –

Danaher OpenFDA by Month

openFDA — MAUDE Adverse Event Reports for the Danaher Ecosystem

Danaher OpenFDA: 573 in Sep 2026, up 644.2% from a year earlier. That is the highest of the 141 months on record here.

Latest, Sep 2026
573
Period ended Sep 30, 2026
Change on a year earlier
+644.2%
77 in Sep 2025
History
141 months
Since Jan 2015
Sources
1
U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE)

Where the Sep 2026 figure comes from

Source: U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗

Reported in U.S. FDA openFDA MAUDE Adverse Event API.

Monthly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedopenFDA — MAUDE Adverse Event Reports for the Danaher EcosystemYear on yearSource
Sep 2026Sep 30, 2026573+644.2%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Aug 2026Aug 31, 2026175+94.4%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Jul 2026Jul 31, 2026187+59.8%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Jun 2026Jun 30, 2026160+53.8%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
May 2026May 31, 2026151+25.8%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Apr 2026Apr 30, 2026156+73.3%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Mar 2026Mar 31, 2026172+42.1%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Feb 2026Feb 28, 202696-18.6%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Jan 2026Jan 31, 202697+21.2%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Dec 2025Dec 31, 2025115+18.6%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Nov 2025Nov 30, 202593+3.3%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Oct 2025Oct 31, 2025118+45.7%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Sep 2025Sep 30, 202577-23.0%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Aug 2025Aug 31, 202590-32.3%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Jul 2025Jul 31, 2025117+34.5%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Jun 2025Jun 30, 2025104+26.8%U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗

Breakdown

What makes up openFDA

Cite this data

StockData. (2026). Danaher OpenFDA, monthly Jan 2015–Sep 2026 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/ext-fda-maude-dhr-total

See every metric in the Danaher KPI table. Data updated Nov 2, 2026.